Sarcos Technology and Robotics Corporation

Laura Peterson serves as President and CEO, having assumed the operational leadership role to drive the commercial deployment of the Guardian line of exoskeletons. Ben Wolff, who orchestrated the SPAC merger that took Sarcos public in 2021, remains Executive Chairman. Under their leadership, the company has shifted from a decades-long government R&D contractor into a commercially focused industrial robotics firm with paying customers in aviation and construction.

Sarcos employs a robots-as-a-service (RaaS) subscription model rather than selling its exoskeletons as outright capital purchases. Customers pay a recurring fee that covers the hardware, software updates, maintenance, and support. This structure reduces the upfront cost barrier for industrial users and generates recurring revenue for Sarcos, which the company positions as a differentiator when negotiating with manufacturers and logistics operators evaluating automation investments.

Publicly disclosed partners include Delta Air Lines, which trialed the Guardian XO full-body exoskeleton for aircraft maintenance technicians, and Black & Veatch, which evaluated Guardian systems on construction sites. Caterpillar Venture Capital participated in Sarcos's PIPE investment at the time of the SPAC merger. The U.S. Navy has contracted Sarcos for maintenance robotics, and the firm has worked on projects for the U.S. Air Force focused on aircraft sustainment operations.

Sarcos went public in September 2021 through a business combination with Rotor Acquisition Corp., a SPAC led by Executive Chairman Ben Wolff. The transaction generated roughly $220 million in gross proceeds, and approximately $175 million in a PIPE from investors including Palantir Technologies, Caterpillar Venture Capital, and Schlumberger. Since the listing, the company has been subject to NASDAQ compliance requirements and conducted a reverse stock split in November 2023 to maintain its listing.

The product portfolio includes the Guardian XT battery-powered exoskeleton for overhead industrial work, the Guardian XO full-body suit for heavy material handling with a 200-pound lift capacity, and the Sapien line of teleoperated dexterous manipulation arms. These systems are designed for manufacturing, logistics, aviation maintenance, and defense sustainment operations where human strength, endurance, or safety is a limiting factor.

Sarcos is revenue-generating but has operated at a loss as it scales commercial production. Its revenue sources include defense contracts with the U.S. Navy and Air Force, commercial pilot programs with industrial partners like Delta Air Lines, and early RaaS subscription agreements. The company reports its financials publicly as a NASDAQ-listed entity, and as of its most recent filings, product revenue remains modest relative to its operating expenses as it invests in manufacturing capacity and software development.

The 2021 merger with Rotor Acquisition Corp. valued Sarcos at approximately $1.3 billion in pro forma enterprise value. The PIPE round raised $175 million from strategic investors including Palantir Technologies, Caterpillar Venture Capital, Schlumberger, and Hercules Capital. These investors represent a mix of technology, industrial equipment, and energy infrastructure firms with potential use cases for Sarcos's robotic systems, suggesting the PIPE was structured as much for commercial alignment as for financial return.